Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Research Journal

The science, examined.

Plain-spoken notes on the compounds we supply — what the literature shows, how to read a COA, and the protocols that protect your data. Cited, never hyped.

All Bioregulators Comparisons Guides Gut Hormonal Immune In the news Metabolic & longevity Methods & QC Nootropics Regulation Sexual health Skin & matrix Sleep Tissue repair
Melanotan I vs Melanotan II: One Approved Medicine, One Grey-Market Agonist Comparisons

Melanotan I vs Melanotan II: One Approved Medicine, One Grey-Market Agonist

They differ by one letter and a world of pharmacology. One is a comparatively selective alpha-MSH analogue licensed as an orphan medicine; the other…

Jun 2026 · 5 min read
Tesofensine vs Enclomiphene: A Research-Use Comparison Comparisons

Tesofensine vs Enclomiphene: A Research-Use Comparison

Two molecules lumped together as metabolic small molecules that share no target, no mechanism and no research question, set side by side.

Jun 2026 · 5 min read
Selank vs Semax: A Research-Use Comparison of Two Russian Regulatory Neuropeptides Comparisons

Selank vs Semax: A Research-Use Comparison of Two Russian Regulatory Neuropeptides

Two synthetic heptapeptides from the same Soviet-era programme, built on different parent molecules and studied along sharply divergent mechanistic lines.

Jun 2026 · 5 min read
NMN vs NAD+: A Research-Use Comparison of NAD Metabolism Precursors Comparisons

NMN vs NAD+: A Research-Use Comparison of NAD Metabolism Precursors

Two compounds, one pathway, one enzymatic step apart. A precise, evidence-honest look at when researchers reach for the precursor versus the coenzyme.

Jun 2026 · 5 min read
GHK-Cu vs AHK-Cu: A Research-Use Comparison of Two Copper-Binding Tripeptides Comparisons

GHK-Cu vs AHK-Cu: A Research-Use Comparison of Two Copper-Binding Tripeptides

Two copper tripeptides differing by a single N-terminal residue — and by decades of evidence. A sober, research-use-only reading of what the literature on…

Jun 2026 · 6 min read
BPC-157 vs TB-500: A Research-Use Comparison Comparisons

BPC-157 vs TB-500: A Research-Use Comparison

Two peptides forever paired in regenerative literature, yet chemically and mechanistically unrelated. What the preclinical record actually says, and why the choice is a…

Jun 2026 · 5 min read
5-Amino-1MQ vs SLU-PP-332: Inhibitor versus Agonist in Metabolic Research Comparisons

5-Amino-1MQ vs SLU-PP-332: Inhibitor versus Agonist in Metabolic Research

Two compounds shelved side by side in metabolic catalogues turn out to share almost nothing at the molecular level — one switches an enzyme…

Jun 2026 · 5 min read
P21: The Neurogenesis Peptide That Has Never Met a Human Nootropics

P21: The Neurogenesis Peptide That Has Never Met a Human

A CNTF-derived fragment rebuilt to cross the blood-brain barrier and switch on BDNF. The rodent data are genuinely striking. The translational record of everything…

Jun 2026 · 6 min read
LL-37: The Self-Defence Peptide That Also Turns on the Self Immune

LL-37: The Self-Defence Peptide That Also Turns on the Self

Humans carry a single cathelicidin. It kills microbes, calls in immune cells and helps wounds close — and, in the wrong context, teaches the…

Jun 2026 · 5 min read
AICAR: The “Exercise in a Pill” That Couldn’t Outrun Its Own Trials Metabolic & longevity

AICAR: The “Exercise in a Pill” That Couldn’t Outrun Its Own Trials

A small molecule made untrained mice run dramatically further. Two decades and several large human trials later, acadesine's record is a study in how…

Jun 2026 · 6 min read
ARA-290: The Peptide That Tried to Split Erythropoietin in Two Immune

ARA-290: The Peptide That Tried to Split Erythropoietin in Two

Cibinetide was engineered to keep erythropoietin's tissue-protective signalling while abandoning its blood-building job. The molecular logic is elegant; the human evidence, gathered mostly in…

Jun 2026 · 5 min read
Spermidine: The Cleanest Case of a Great Mechanism Meeting Mediocre Trials Metabolic & longevity

Spermidine: The Cleanest Case of a Great Mechanism Meeting Mediocre Trials

A naturally occurring polyamine that induces autophagy from yeast to mice, backed by striking mortality epidemiology — and undercut by randomised human trials that…

Jun 2026 · 8 min read
Previous Page 11 of 17 Next

New research, in your inbox

Occasional, considered notes on the compounds and the literature. No noise.

Subscribe & earn 500 points